MedVi vs Brello: Semaglutide promos and verification compared
Quick verdict: MedVi vs Brello
The primary difference in this MedVi vs Brello comparison is verification and upfront pricing. MedVi advertises compounded semaglutide starting at $179 for the first month with a fully online intake, no clinic visits, and 24/7 certified medical support. Brello’s captured landing-page details, including pricing and eligibility, were not verified.
How the two platforms differ at a glance
This direct comparison focuses on the most distinctive supported differences: promotional first-month pricing and verification, whether details are published or captured, medication type and regulatory status, and the care model including clinic visits and support. The comparison uses only the facts captured for each provider.
1. Verified promotional pricing and cost structure
MedVi: Winter promotional price for the first month is $179, including fast, free shipping. The source states the ongoing standalone month rises to $299 and a three-month plan is available at $649 (about $216/month). These price points and the promo are explicitly reported in the captured evidence.
Brello: A starting price value of 133 is recorded in the source row, but the captured landing-page details were not verified. The summary explicitly notes that current details were not published or could not be verified on the captured affiliate landing page.
Check Brello eligibility and live offer
2. Verification and available public details
MedVi: Landing-page evidence was captured and reviewed. The source includes specific promotional text, pricing breakdown, and program details captured from MedVi’s landing page.
Brello: The captured affiliate landing page timed out or did not publish verifiable details. The source explicitly lists “No readable evidence captured” and that current details were not published or could not be verified.
3. Medication type and regulatory notes
MedVi: Provides clinically dosed compounded semaglutide. The source repeatedly notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. MedVi’s platform states compounded semaglutide uses the same active ingredient as Ozempic and Wegovy, but the regulatory note about compounded drugs is preserved in the source.
Brello: The captured row states that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. No further medication specifics were captured.
4. Care model and clinician review
MedVi: The process is fully online with a simple intake, no clinic visits, and an online clinician review. OpenLoop Health clinicians meet with users after checkout and retain the decision to prescribe compounded GLP-1s. MedVi also markets 24/7 support from certified medical professionals.
Brello: The available capture notes that treatment is clinician-reviewed and only provided when medically appropriate. The captured page emphasizes confirming eligibility, medication, total cost, renewal terms, and state availability before enrollment, but does not publish detailed workflow captured in the landing-page evidence.
Comparison table: MedVi vs Brello
| Criteria | MedVi | Brello |
|---|---|---|
| Starting price (captured) | $179 first month promo (captured) | $133 noted but not verified |
| Price verification | Landing-page evidence captured and reviewed | Details not published or not verified on captured page |
| Medication type | Compounded semaglutide (clinically dosed) | Not specified in captured evidence; compounded when offered noted |
| Clinician review | Online clinician review; no clinic visits required | Treatment only when licensed clinician determines appropriate |
| Support and shipping | 24/7 certified medical support; fast, free shipping on promo | Shipping and support not verified on captured page |
| Regulatory note | Compounded medications not FDA-approved; captured regulatory guidance | Compounded medications not FDA-approved; status must be confirmed |
5. What is explicitly not supplied
The captured Brello landing-page did not provide verifiable pricing breakdowns, membership terms, shipping details, or a captured FAQ. Any details beyond the statements above were not captured or verified and are not included in this comparison.
See MedVi program details and clinician review
Bottom line and who should choose which provider
In this MedVi vs Brello comparison, MedVi is the clearer option when you want a verified promotional first-month price and a fully captured online process including no clinic visits and 24/7 certified medical support. Brello is a choice only for people who confirm eligibility, medication, total cost, renewal terms and state availability directly with Brello because the captured landing-page did not verify those details.
Begin MedVi intake and view pricing
Confirm Brello live offer and eligibility
Choose MedVi if…
- You want a captured promotional first-month price of $179 and a documented online intake with no clinic visits.
- You prioritize clinically dosed compounded semaglutide and 24/7 certified medical support as reported in the source.
Choose Brello if…
- You will confirm eligibility, medication, pricing, renewal terms and state availability directly with Brello because those details were not verified on the captured page.